Remedium Lifecare Ltd
Fundamental Score
Remedium Lifecare Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of REMLIFE across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
9 factors identified
Premium Valuation Risk (P/E: 44.72x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Elevated Debt Levels (D/E: 10.34)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability and cash flow generation.
Weak Interest Coverage (1.57x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
Low Promoter Commitment (1.13%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
High Debt-to-Equity Ratio
Observation: Elevated financial risk due to high leverage.
Analysis: High debt levels may strain cash flows and increase financial risk during economic downturns.
Very High Debt Levels
Observation: Excessive leverage may strain cash flows.
Analysis: Debt-to-equity above 2.0 indicates potential financial distress risk.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Remedium Lifecare Ltd
About REMLIFE
Business Overview
Supha Pharmachem Limited, a pharmaceutical company, trades and sells active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, iodine, selenium metal powder, and trimethyl sulfoxonium iodide. It also provides tartaric acid salt, thiophenetosylate, couple amine hydrochloride, pantoprazole sulphide, chloro compound, benzimidazole, pantoprazole n-oxide, 4-chloro benzhydryl piperazine, cetirizine base, levo CBP, 2 PMS, indole II, indole III, and R- amide. The company was formerly known as Remedium Lifecare Limited and changed its name to Supha Pharmachem Limited in December 2025. Supha Pharmachem Limited was incorporated in 1988 and is based in Mumbai, India.
Company Details
Key Leadership
Latest News
REMLIFE Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Remedium Lifecare Ltd (REMLIFE)?
As of 20 Jan 2026, 10:58 am IST, Remedium Lifecare Ltd (REMLIFE) is currently trading at ₹0.85. The stock has a market capitalization of ₹95.26 (Cr).
Is REMLIFE share price Overvalued or Undervalued?
REMLIFE is currently trading at a P/E ratio of 44.72x, compared to the industry average of 35.45x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Remedium Lifecare Ltd share price?
Key factors influencing REMLIFE's price include its quarterly earnings growth (Sales Growth: N/A%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Remedium Lifecare Ltd a good stock for long-term investment?
Remedium Lifecare Ltd shows a 5-year Profit Growth of N/A% and an ROE of N/A%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 10.34 before investing.
How does Remedium Lifecare Ltd compare with its industry peers?
Remedium Lifecare Ltd competes with major peers in the Trading & Distributors. Investors should compare REMLIFE's P/E of 44.72x and ROE of N/A% against the industry averages to determine its competitive standing.
What is the P/E ratio of REMLIFE and what does it mean?
REMLIFE has a P/E ratio of 44.72x compared to the industry average of 35.45x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹45 for every ₹1 of annual earnings.
How is REMLIFE performing according to Bull Run's analysis?
REMLIFE has a Bull Run fundamental score of N/A/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does REMLIFE belong to?
REMLIFE operates in the Trading & Distributors industry. This classification helps understand the competitive landscape and sector-specific trends affecting Remedium Lifecare Ltd.
What is Return on Equity (ROE) and why is it important for REMLIFE?
REMLIFE has an ROE of N/A%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Remedium Lifecare Ltd generates profits from shareholders' equity.
How is REMLIFE's debt-to-equity ratio and what does it indicate?
REMLIFE has a debt-to-equity ratio of 10.34, which indicates high leverage that increases financial risk. A ratio below 1.0 generally indicates conservative financing.
What is REMLIFE's dividend yield and is it a good dividend stock?
REMLIFE offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has REMLIFE grown over the past 5 years?
REMLIFE has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in REMLIFE and why does it matter?
Promoters hold 1.13% of REMLIFE shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is REMLIFE's market capitalization category?
REMLIFE has a market capitalization of ₹95 crores, placing it in the Small-cap category.
How volatile is REMLIFE stock?
REMLIFE has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for REMLIFE?
REMLIFE has a 52-week high of ₹N/A and low of ₹N/A.
What is REMLIFE's operating profit margin trend?
REMLIFE has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is REMLIFE's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of N/A% and YoY Profit Growth of N/A%.
What is the institutional holding pattern in REMLIFE?
REMLIFE has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.